1. Home
  2. BWEN vs FHTX Comparison

BWEN vs FHTX Comparison

Compare BWEN & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$2.93

Market Cap

100.5M

Sector

Industrials

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$2.00

Market Cap

111.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
FHTX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.5M
111.1M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
BWEN
FHTX
Price
$2.93
$2.00
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
★ $6.83
$4.17
AVG Volume (30 Days)
177.8K
★ 1.2M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 360.00
25.32
EPS
★ N/A
N/A
Revenue
★ $146,785,000.00
$30,909,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.73
$15.98
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 36.75
52 Week Low
$1.92
$1.79
52 Week High
$5.70
$7.61

Technical Indicators

Market Signals
Indicator
BWEN
FHTX
Relative Strength Index (RSI) 24.27 24.78
Support Level $1.98 $1.79
Resistance Level $3.35 $5.27
Average True Range (ATR) 0.19 0.14
MACD -0.09 0.09
Stochastic Oscillator 0.00 58.57

Price Performance

Historical Comparison
BWEN
FHTX

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: